Literature DB >> 1650307

Inhibition of alveolar macrophages by pentoxifylline.

J H Williams1, S Heshmati, S Tamadon, J Guerra.   

Abstract

BACKGROUND AND METHODS: Pentoxifylline can inhibit blood leukocyte functions in vitro, and some inflammatory processes in the lung in vivo. Therefore, we examined the effects of pentoxifylline on alveolar macrophage functions in vitro. Alveolar macrophages were harvested from normal rat lungs by airway lavage. The dose-response relationship of varying concentrations of pentoxifylline and in vitro cell functions were examined. Macrophage functions studied included adherence to nylon wool, random (unstimulated) and zymosan-activated serum-stimulated migration through 5 microns millipore filters, and superoxide generation induced by zymosan-activated serum as assayed by cytochrome c reduction.
RESULTS: Pentoxifylline inhibited superoxide generation and stimulated migration (but not random migration or adherence) in a dose-dependent fashion. Statistically significant inhibition was demonstrated at 0.5 mM and 5.0 mM concentrations of pentoxifylline, respectively, for stimulated migration and superoxide generation.
CONCLUSIONS: Pentoxifylline can inhibit some alveolar macrophage functions in vitro. These effects may inhibit some forms of inflammatory lung injury, particularly when iv infusion of high doses of pentoxifylline are utilized. However, potentially adverse effects on inflammatory defense mechanisms must be considered as well.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1650307     DOI: 10.1097/00003246-199108000-00017

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  4 in total

1.  Prophylactic anti-inflammation inhibits cigarette smoke-induced emphysema in guinea pigs.

Authors:  Jinnong Zhang; Xiaonan Tao; Jianmin Xie; Min Xiang; Wei Fu
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2003

2.  Inhibition of tumor necrosis factor-alpha (TNF-alpha) and interleukin-1 beta (IL-1 beta) secretion but not IL-6 from activated human peripheral blood monocytes by a new synthetic demethylpodophyllotoxin derivative.

Authors:  X H Gan; J P Robin; J M Huerta; P Braquet; B Bonavida
Journal:  J Clin Immunol       Date:  1994-09       Impact factor: 8.317

3.  Pentoxifylline suppresses interleukin-2-mediated activation of immature human natural killer cells by inhibiting endogenous tumor necrosis factor-alpha secretion.

Authors:  A Jewett; B Bonavida
Journal:  J Clin Immunol       Date:  1994-01       Impact factor: 8.317

4.  Pentoxifylline immunomodulation in the treatment of experimental chronic pulmonary paracoccidioidomycosis.

Authors:  Damaris Elena Lopera; Tonny Williams Naranjo; José Miguel Hidalgo; Laura Echeverri; Jairo Hernando Patiño; Ángela Restrepo Moreno; Henrique Leonel Lenzi; Luz Elena Cano
Journal:  Fibrogenesis Tissue Repair       Date:  2015-06-01
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.